Evidence map›Paper›PMID 38305896›Full record

ArticleArchives of women's mental health2024

Partner support for women's antidepressant treatment and its association with depressive symptoms in pregnant women, mothers, and women planning pregnancy.

Tania Nasrin, Fatima Tauqeer, Ludvig D Bjørndal, Sarah Kittel-Schneider, Angela Lupattelli

Open access · hybridAbstract read
In one paragraph

Article in Archives of women's mental health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Tania NasrinDepartment of Community Medicine and Global Health, Faculty of Medicine, University of Oslo, 0316, Oslo, Norway.ORCID 0000-0002-4232-6629
Fatima TauqeerPharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Blindern, PO Box 1068, 0316, Oslo, Norway.ORCID 0000-0001-8167-9243
Ludvig D BjørndalPROMENTA Research Center, Department of Psychology, University of Oslo, 0317, Oslo, Norway.ORCID 0000-0001-9773-8287
Sarah Kittel-SchneiderDepartment of Psychiatry and Neurobehavioural Science, University College Cork, Acute Adult Mental Health Unit, Cork University Hospital, Wilton, Cork, T12DC4A, Ireland.ORCID 0000-0003-3057-6150
Angela LupattelliPharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Blindern, PO Box 1068, 0316, Oslo, Norway. angela.lupattelli@farmasi.uio.no.ORCID 0000-0002-8787-3183
University of Oslo · NOUniversity College Cork · IE

Funding

Norges Forskningsråd 288696
6 · The paper itself

Abstract

purposeTo examine the association between partner support for women's antidepressant treatment and depressive symptoms in pregnant women, those planning pregnancy, and mothers who ever used antidepressants.

methodsWe included 334 women (n=44 planners, n=182 pregnant, n=108 mothers) ever treated with antidepressants within the HEALTHx2 study, a web-based cross-sectional study conducted across Norway in June 2020 to June 2021. The Edinburgh Postnatal Depression Scale and two questions of the Patient Health Questionnaire measured depressive symptoms, by degree of severity and for depressed mood, anxiety, and anhedonia sub-dimensions. Partner support was measured using one item from the Antidepressant Compliance Questionnaire. Association was estimated via unadjusted and adjusted linear and logistic regression models.

resultsBeing unsupported by the partner was associated with increased odds of reporting moderate-to-very-severe depressive symptoms in mothers (adjusted odds ratio (aOR), 3.57; 95% confidence interval (CI), 1.04-12.19) and pregnant women (aOR, 3.26; 95% CI, 0.95-11.14), relative to being supported. Pregnant women (adjusted mean difference (β), 0.76; 95% CI, 0.14-1.38) and mothers (β, 0.93; 95% CI, 0.23-1.64) with no support for their antidepressant treatment presented greater symptoms of anhedonia; for women planning pregnancy, this association emerged in relation to anxiety symptoms (β among non-users of antidepressant, 2.58; 95% CI, 1.04-4.13).

conclusionsPartner support for women's antidepressant treatment may play a key role in depressive symptoms severity and the subtypes of anhedonia and anxiety, among women planning pregnancy, pregnant women, and mothers. This highlights the importance of partner inclusion in the complex decision-making process for antidepressant treatment around the time of pregnancy.

Indexed as

Antidepressive AgentsDepressionMothersPregnant PeopleAdultCross-Sectional StudiesFemaleHumansNorwayPregnancyPregnancy ComplicationsPsychiatric Status Rating ScalesSexual PartnersSocial SupportSpousesSurveys and QuestionnairesAntidepressive AgentsAntidepressantDepressive symptomsPartner supportPostpartumPreconceptionalPregnancy

Identifiers

PMID38305896
PMCPMC11230968
OpenAlexW4391474408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.